CONGRESSMAN MORELLE ANNOUNCES $3.4 MILLION IN FUNDING FOR CANCER RESEARCH AT UNIVERSITY OF ROCHESTER
(Rochester, NY) – Today, Congressman Joe Morelle announced that $3.4 million in funding from the National Cancer Institute (NCI) has been awarded to the University of Rochester Wilmot Cancer Institute over a five-year period. This grant will fund critical cancer treatment research, making NCI-supported clinical trials more accessible to patients.
“I’m so pleased that the University of Rochester has received this significant grant, which will help support their innovative and ground-breaking medical research,” said Rep. Morelle. “I know all too well the devastating impact cancer can have on a family. Investments like this are essential to advancing research and education that will finally lead to a cure for this awful disease.”
“Clinical trials are a vital step in bringing new cancer treatments to patients,” said Paul M. Barr, M.D., who leads Wilmot’s Clinical Trials Office and is the principal investigator on this grant. “This funding will help us expand access to important national clinical trials in our region and ultimately shape cancer care nationwide.”
The Wilmot Cancer Institute is one of only about 30 centers nationally to receive this award, known as a Lead Academic Participating Site grant. The grant supports research and infrastructure for clinical trials and will allow the U of R to play a leadership role in setting national priorities for cancer-related clinical research.